Else Nutrition to Expand to Walmart.com this November, Adding Kids Plant-Based Shakes to Listings
12 Octobre 2021 - 1:00PM
ELSE NUTRITION HOLDINGS INC.
(BABY.V)
(BABYF)
(0YL.F) ("Else" or the
"Company") the plant-based baby, toddler and
children nutrition company, announces that it will be proceeding
with its online distribution agreement with Walmart.com by November
2021, with its launch of Plant-Based Complete Nutrition for Toddler
and Kids product range.
“This is another great development for the
Company, enabling Else to market both our Toddler and Kids product
line on one of the world’s largest online marketplaces,” said Else
Nutrition CEO & Co-Founder, Hamutal Yitzhak. “Not only will
this further accelerable our already rapid growth of online sales,
but it also serves as a paramount piece to the introduction of our
Kids product line to the wanting families from coast to coast,” she
added.
According to eMarketer, Walmart’s U.S.
e-commerce sales prior to the pandemic were $30 billion and are
projected to hit over $64 billion by the end of 2021. During
the year, sales have grown though increased customer demand for
eating at home, entertaining, etc.
Walmart.com’s traffic was much higher than
pre-pandemic levels (for example, there was a 48% increase compared
to the same quarter two years ago). Online shopping,
particularly in the grocery and FMCG segment (Fast Moving Consumer
Goods), has undergone a surge in popularity due to the
pandemic.
Else Nutrition announced the Walmart.com
distribution agreement earlier this year in August, and since has
added the additional listings of the Kids products.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food
and nutrition company focused on developing innovative, clean and
plant-based food and nutrition products for infants, toddlers,
children, and adults. Its revolutionary, plant-based, non-soy,
formula is a clean-ingredient alternative to dairy-based formula.
Else Nutrition (formerly INDI) won the "2017 Best Health and Diet
Solutions" award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently
ranked as the #1 Top seller in the baby and toddler formula
category on Amazon. The holding company, Else Nutrition Holdings
Inc., is a publicly traded company, listed as TSX Venture Exchange
under the trading symbol BABY and is quoted on the US OTC Markets
QX board under the trading symbol BABYF and on the Frankfurt
Exchange under the symbol 0YL. Else's Executives includes
leaders hailing from leading infant nutrition companies. Many
of Else advisory board members had past executive roles in
companies such as Mead Johnson, Abbott Nutrition, Plum Organics and
leading infant nutrition Societies, and some of them
currently serve in different roles in leading medical centers and
academic institutes such as Boston Children's Hospital, Pediatrics
at Harvard Medical School, USA, Tel Aviv University, Schneider
Children's Medical Center of Israel, Rambam Medical Center and
Technion, Israel and University Hospital Brussels, Belgium.
For more information,
visit: elsenutrition.com or @elsenutrition on Facebook
and Instagram.
Media ContactErin JundefBrilliant
PRerinj@brilliantpr.com
For more information, contact:Mrs. Hamutal
Yitzhak, CEO, Co-Founder & DirectorELSE Nutrition Holdings
Inc.E: hamutaly@elsenutrition.comP: +972(0)3-6445095
Mr. Sokhie Puar, Director of Else
NutritionE: sokhiep@elsenutrition.comP: 604-603-7787
TSX Venture Exchange
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the Company’s financial disclosure documents. Such
forward-looking statements reflect current estimates, beliefs and
assumptions, which are based on management’s perception of current
conditions and expected future developments, as well as other
factors management believes are appropriate in the circumstances.
No assurance can be given that the foregoing will prove to be
correct. Forward-looking statements made in this press release
assume, among others, the expectation that there will be no
interruptions or supply chain failures as a result of COVID 19 and
that the manufacturing, broker and supply logistic agreement with
the Company do not terminate. Actual results may differ from the
estimates, beliefs and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not
to place undue reliance on any forward-looking statements, which
reflect management’s expectations only as of the date of this press
release. The Company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/3a0e6f00-b2e9-4448-a032-54c28ba0f17d
Else Nutrition (TSXV:BABY)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Else Nutrition (TSXV:BABY)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024